Mesenchymal Stem Cell Exosomes as Immunomodulatory Therapy for Corneal Scarring
International Journal of Molecular Sciences · 18.04.2023 · 24 (8) · 7456
DOI: 10.3390/ijms24087456 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Journal of Molecular Sciences, online erschienen am 18.04.2023. Verfasst von Hon Shing Ong und 8 weiteren Autor:innen. Beteiligte Einrichtung: Tissue Engineering and Cell Therapy Group, Singapore Eye Research Institute, Singapore 169856, Singapore. Hauptthemen laut MEDLINE: Exosomes, Corneal Injuries, Mesenchymal Stem Cells. Die Arbeit wurde bisher 54-mal zitiert (Crossref) und nennt 77 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Medical Research Council, SERI-Lee Foundation, Health and Biomedical Sciences (HBMS) Industry Aligned Fund Pre-Positioning (IAF-PP).
Abstract (Originalsprache)
Corneal scarring is a leading cause of worldwide blindness. Human mesenchymal stem cells (MSC) have been reported to promote corneal wound healing through secreted exosomes. This study investigated the wound healing and immunomodulatory effects of MSC-derived exosomes (MSC-exo) in corneal injury through an established rat model of corneal scarring. After induction of corneal scarring by irregular phototherapeutic keratectomy (irrPTK), MSC exosome preparations (MSC-exo) or PBS vehicle as controls were applied to the injured rat corneas for five days. The animals were assessed for corneal clarity using a validated slit-lamp haze grading score. Stromal haze intensity was quantified using in-vivo confocal microscopy imaging. Corneal vascularization, fibrosis, variations in macrophage phenotypes, and inflammatory cytokines were evaluated using immunohistochemistry techniques and enzyme-linked immunosorbent assays (ELISA) of the excised corneas. Compared to the PBS control group, MSC-exo treatment group had faster epithelial wound closure (0.041), lower corneal haze score (p = 0.002), and reduced haze intensity (p = 0.004) throughout the follow-up period. Attenuation of corneal vascularisation based on CD31 and LYVE-1 staining and reduced fibrosis as measured by fibronectin and collagen 3A1 staining was also observed in the MSC-exo group. MSC-exo treated corneas also displayed a regenerative immune phenotype characterized by a higher infiltration of CD163+, CD206+ M2 macrophages over CD80+, CD86+ M1 macrophages (p = 0.023), reduced levels of pro-inflammatory IL-1β, IL-8, and TNF-α, and increased levels of anti-inflammatory IL-10. In conclusion, topical MSC-exo could alleviate corneal insults by promoting wound closure and reducing scar development, possibly through anti-angiogenesis and immunomodulation towards a regenerative and anti-inflammatory phenotype.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Tissue Engineering and Cell Therapy Group, Singapore Eye Research Institute, Singapore 169856, Singapore.
- Ophthalmology and Visual Sciences Academic Clinical Program, Duke-NUS Medical School, Singapore 169857, Singapore.
- Corneal and External Diseases Department, Singapore National Eye Centre, Singapore 168751, Singapore.
- Department of Ophthalmology, University of Pittsburgh, Pittsburgh, PA 15213, USA.
- Institute of Medical Biology & Institute of Molecular and Cell Biology, Agency for Science, Technology and Research (A*STAR), Singapore 138648, Singapore.
- School of Materials Science and Engineering, Nanyang Technological University, Singapore 639798, Singapore.
ORCID-Profile: Hon Shing Ong, Andri K Riau, Gary Hin-Fai Yam, Ruenn Chai Lai, Jodhbir S Mehta
Förderung
- National Medical Research Council
- SERI-Lee Foundation
- Health and Biomedical Sciences (HBMS) Industry Aligned Fund Pre-Positioning (IAF-PP)
- SERI-Lee Foundation Pilot Grant
- NMRC Clinician Scientist Award-Senior Category
- NMRC Clinician-Scientist Individual Research Grant New Investigator Grant (CS-IRG-NIG)
Zitieren
APA
Ong, H. S., Riau, A. K., Yam, G. H., Yusoff, N. Z. B. M., Han, E. J. Y., Goh, T. W., Lai, R. C., Lim, S. K., & Mehta, J. S. (2023). Mesenchymal Stem Cell Exosomes as Immunomodulatory Therapy for Corneal Scarring. International Journal of Molecular Sciences, 24(8), 7456. https://doi.org/10.3390/ijms24087456
Vancouver
Ong HS, Riau AK, Yam GH, Yusoff NZBM, Han EJY, Goh TW, et al. Mesenchymal Stem Cell Exosomes as Immunomodulatory Therapy for Corneal Scarring. International Journal of Molecular Sciences. 2023;24(8):7456. doi:10.3390/ijms24087456
BibTeX
@article{Ong2023,
author = {Ong, Hon Shing and Riau, Andri K and Yam, Gary Hin-Fai and Yusoff, Nur Zahirah Binte M and Han, Evelina J Y and Goh, Tze-Wei and Lai, Ruenn Chai and Lim, Sai Kiang and Mehta, Jodhbir S},
title = {Mesenchymal Stem Cell Exosomes as Immunomodulatory Therapy for Corneal Scarring},
journal = {International Journal of Molecular Sciences},
year = {2023},
volume = {24},
number = {8},
pages = {7456},
doi = {10.3390/ijms24087456}
}
EUVIMED